The CDC and FDA have released their data that indicate the Covid vaccines were certainly not safe. From Dr. Joseph Mercola at theburningplatform.com:
- In September 2022, The Epoch Times asked the U.S. Centers for Disease Control and Prevention to release its Proportional Reporting Ratio (PRR) data mining results. The CDC refused. A Freedom of Information Act (FOIA) request has now forced the release of these data, and they are stunning
- The CDC’s PRR monitoring has identified several hundred safety signals, including for Bell’s palsy, blood clots, pulmonary embolism and death. In individuals aged 18 and older, there are 770 safety signals for different adverse events, and more than 500 of them have a stronger safety signal than myocarditis and pericarditis
- In the 12- to 17-year-old age group there are 96 safety signals, and in the 5- to 11-year-old group there are 66, including myocarditis, pericarditis, ventricular dysfunction, cardiac valve incompetency, pericardial and pleural effusion, chest pain, appendicitis and appendectomies, Kawasaki’s disease and vitiligo
- The proportions of deaths, which were only provided for the 18-plus age group, was 14% for the COVID jabs compared to 4.7% for all other vaccines
- The FDA is also required to perform safety monitoring, using empirical Bayesian data mining. The Epoch Times asked the FDA to release its monitoring results in July 2022 but, like the CDC, the FDA refused, only to admit in December 2022 they’d confirmed the Pfizer shot was linked to pulmonary embolism
In September 2022, The Epoch Times asked the U.S. Centers for Disease Control and Prevention to release its Proportional Reporting Ratio (PRR) data mining results. PRR1 measures how common an adverse event is for a specific drug compared to all the other drugs in the database.
According to the standard operating procedures2,3 for the Vaccine Adverse Event Reporting System (VAERS), which is run jointly by the CDC and the Food and Drug Administration, the CDC is required to perform these data mining analyses.